IL6 and glioblastoma: However, given the complexity of the tumour microenvironment within glioblastoma and the predominance of immunosuppressive macrophages and microglia, an enhanced inflammatory response especially involving IL-6/JAK/STAT3 pathways may enhance immunosuppression and inadequate T-cell response [49].